首页> 外文期刊>American journal of clinical pathology. >Spurious hemoglobin Barts caused by bilirubin: a common interference mimicking an uncommon hemoglobinopathy.
【24h】

Spurious hemoglobin Barts caused by bilirubin: a common interference mimicking an uncommon hemoglobinopathy.

机译:胆红素引起的虚假血红蛋白Barts:模仿一种罕见的血红蛋白病的常见干扰。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

High-performance liquid chromatography (HPLC) is replacing electrophoresis for identification of hemoglobin variants. Our objective was to identify unknown tall peaks with elution times and shapes of hemoglobin Barts found on hemoglobin chromatograms that could not be confirmed by alkaline and acid gel electrophoresis. Of 90 specimens identified with this peak, 86 were from patients with hemoglobin SS. Regression of the height of the unknown peaks to serum bilirubin concentrations, diminution of the unknown peaks by washing the specimens, and chromatographic similarity of a total bilirubin serum calibrator, a bilirubin proficiency testing specimen, and 3 patients' serum samples with markedly elevated bilirubin to hemoglobin Barts provide evidence the peak was bilirubin. We suggest exclusion of bilirubin before HPLC results are reported as consistent with hemoglobin Barts.
机译:高效液相色谱(HPLC)取代了电泳技术,用于鉴定血红蛋白变体。我们的目标是鉴定在血红蛋白色谱图上发现的未知洗脱时间和血红蛋白Barts形状的未知高峰,而碱性和酸性凝胶电泳无法确定这些峰。在鉴定出该峰的90个样本中,有86个来自血红蛋白SS患者。未知峰的高度向血清胆红素浓度的回归,通过洗涤标本减少未知峰,总胆红素血清校准物,胆红素水平测试标本和3例患者血清样品中胆红素显着升高的色谱相似性血红蛋白巴茨提供的证据是胆红素峰值。我们建议在报道HPLC结果与血红蛋白Barts一致之前排除胆红素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号